These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Low serum iron status and akathisia. Brown KW; Glen SE; White T Lancet; 1987 May; 1(8544):1234-6. PubMed ID: 2884371 [TBL] [Abstract][Full Text] [Related]
23. Legal aspects of neuroleptic-induced movement disorders. Wettstein RM Leg Med; 1985; ():117-79. PubMed ID: 2872562 [No Abstract] [Full Text] [Related]
24. Treatment of extrapyramidal side effects with terguride. Filip V; Marsálek M; Hálková E; Karen P Psychiatry Res; 1992 Jan; 41(1):9-16. PubMed ID: 1348584 [TBL] [Abstract][Full Text] [Related]
25. Successful clonazepam treatment of neuroleptic-induced akathisia in older adolescents and young adults: a double-blind, placebo-controlled study. Kutcher S; Williamson P; MacKenzie S; Marton P; Ehrlich M J Clin Psychopharmacol; 1989 Dec; 9(6):403-6. PubMed ID: 2574191 [TBL] [Abstract][Full Text] [Related]
26. Assessment of extrapyramidal symptoms during acute neuroleptic treatment. Mazure CM; Cellar JS; Bowers MB; Nelson JC; Takeshita J; Zigun B J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736 [TBL] [Abstract][Full Text] [Related]
27. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients. Richardson MA; Haugland G; Craig TJ Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296 [TBL] [Abstract][Full Text] [Related]
29. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?]. Peschel O; Kurtz G; Müller-Felber W; Modell S Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573 [TBL] [Abstract][Full Text] [Related]
30. Serum iron and akathesia. Friedman EH Biol Psychiatry; 1991 Nov; 30(10):1064-5. PubMed ID: 1684517 [No Abstract] [Full Text] [Related]
31. Movement disorders with neuroleptic drug treatment. Tarsy D Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742 [TBL] [Abstract][Full Text] [Related]
32. Persistent akathisia associated with early tardive dyskinesia. Barnes TR; Braude WM Postgrad Med J; 1984 May; 60(703):359-61. PubMed ID: 6146131 [TBL] [Abstract][Full Text] [Related]
33. [Akathisia--diagnosis, pathophysiology and therapy]. Zyss T; Banach M; Zieba A Psychiatr Pol; 2009; 43(4):387-402. PubMed ID: 20128247 [TBL] [Abstract][Full Text] [Related]
34. The epidemiology of drug-induced akathisia: Part I. Acute akathisia. Sachdev P Schizophr Bull; 1995; 21(3):431-49. PubMed ID: 7481574 [TBL] [Abstract][Full Text] [Related]
35. Drug-induced movement disorders. Gershanik OS Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509 [TBL] [Abstract][Full Text] [Related]
36. The effect of activation procedures on neuroleptic-induced akathisia. Fleischhacker WW; Miller CH; Barnas C; Bergmann K; Perovich R; Alvir JM; Lieberman JA; Kane JM Br J Psychiatry; 1993 Dec; 163():781-4. PubMed ID: 7905775 [TBL] [Abstract][Full Text] [Related]
37. Psychotic patients' interpretation of neuroleptic side effects. Lavin MR; Rifkin A Am J Psychiatry; 1991 Nov; 148(11):1615-6. PubMed ID: 1681754 [No Abstract] [Full Text] [Related]